dynorphin (1-8) has been researched along with leucine in 2 studies
Studies (dynorphin (1-8)) | Trials (dynorphin (1-8)) | Recent Studies (post-2010) (dynorphin (1-8)) | Studies (leucine) | Trials (leucine) | Recent Studies (post-2010) (leucine) |
---|---|---|---|---|---|
173 | 0 | 3 | 28,515 | 744 | 4,178 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayala, JM; Molineaux, CJ | 1 |
Gillan, MG; Kosterlitz, HW; McKnight, AT; Robson, LE | 1 |
2 other study(ies) available for dynorphin (1-8) and leucine
Article | Year |
---|---|
An inhibitor of endopeptidase-24.15 blocks the degradation of intraventricularly administered dynorphins.
Topics: Animals; Brain; Captopril; Cerebral Ventricles; Choroid Plexus; Dynorphins; Enkephalin, Leucine; Kinetics; Leucine; Male; Metalloendopeptidases; Neprilysin; Oligopeptides; Peptide Fragments; Peptidyl-Dipeptidase A; Perfusion; Rats; Rats, Inbred Strains | 1990 |
[3H]-Dynorphin A (1-8): degradation profile and binding characteristics in brain homogenates.
Topics: Animals; Brain; Captopril; Dynorphins; Guinea Pigs; Leucine; Peptide Fragments; Receptors, Opioid; Receptors, Opioid, kappa | 1985 |